ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,448Medicare Part D Prescriptions Filled, Including Refills

Rank: 87 out of 917

$517K Total Retail Price of All Prescriptions

Rank: 107 out of 917

584 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 584 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

9% of this provider’s 584 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 8,203 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
LISINOPRIL 488 416 1 1
SIMVASTATIN 412 312 2 2
AMLODIPINE BESYLATE 376 324 3 5
FUROSEMIDE 368 310 4 7
WARFARIN SODIUM 355 240 5 10
OMEPRAZOLE 294 245 6 4
METFORMIN HCL 258 211 7 8
LEVOTHYROXINE SODIUM 238 171 8 3
GABAPENTIN 216 105 9 17
METOPROLOL TARTRATE 196 165 10 11
CITALOPRAM HBR 191 170 11 15
HYDROCHLOROTHIAZIDE 190 157 12 9
POTASSIUM CHLORIDE 180 162 13 16
TRAZODONE HCL 138 113 14 22
LOSARTAN POTASSIUM 138 128 14 13
CARVEDILOL 137 128 16 33
TAMSULOSIN HCL 136 134 17 25
LOVASTATIN 134 127 18 19
LANTUS 134 83 18 37
NAMENDA 132 132 20 43
GLIPIZIDE 118 96 21 40
PRAVASTATIN SODIUM 115 112 22 20
HYDROCODONE-ACETAMINOPHEN 113 74 S3 23 6
DIGOXIN 108 105 24 41
ATORVASTATIN CALCIUM 99 78 25 14
ZOLPIDEM TARTRATE 94 79 26 21
RANITIDINE HCL 94 45 26 29
ATENOLOL 92 82 28 12
ALLOPURINOL 92 80 28 31
MIRTAZAPINE 91 81 30 39
DONEPEZIL HCL 91 91 30 32
OXYCODONE HCL 90 73 S2 32 27
TRAMADOL HCL 86 39 33 28
METOPROLOL SUCCINATE 84 71 34 18
SERTRALINE HCL 81 41 35 24
FLUTICASONE PROPIONATE 77 63 36 26
NOVOLOG 72 31 37 98
PANTOPRAZOLE SODIUM 67 63 38 44
PREDNISONE 65 47 39 34
ALENDRONATE SODIUM 64 59 40 23
SPIRIVA 63 44 41 45
CYMBALTA 62 0 42 56
CIPROFLOXACIN HCL 62 50 42 72
OXYBUTYNIN CHLORIDE 61 38 44 76
ROPINIROLE HCL 59 48 45 88
GLYBURIDE 58 44 R 46 71
CYCLOBENZAPRINE HCL 58 24 R 46 65
LISINOPRIL-HYDROCHLOROTHIAZIDE 57 44 48 42
PROAIR HFA 57 36 48 35
ADVAIR DISKUS 52 37 50 47
AMITRIPTYLINE HCL 52 23 R 50 67
CLOPIDOGREL 51 51 52 50
QUETIAPINE FUMARATE 50 41 53 52
ISOSORBIDE MONONITRATE ER 50 46 53 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 30, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.